Literature DB >> 15245529

Scleroderma and the taxanes. Is there really a link?

P B J Farrant1, P S Mortimer, M Gore.   

Abstract

Scleroderma has been associated with exposure to many substances in the past ranging from vinyl chloride to silicon dioxide. In recent years there have been a number of case reports linking modern chemotherapy agents, such as the taxanes to the development of scleroderma like changes. We present a further case of scleroderma in association with chemotherapy but question the role of some of the agents previously implicated. A brief review of the current literature is included.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15245529     DOI: 10.1111/j.1365-2230.2004.01519.x

Source DB:  PubMed          Journal:  Clin Exp Dermatol        ISSN: 0307-6938            Impact factor:   3.470


  5 in total

Review 1.  Dermatological adverse events with taxane chemotherapy.

Authors:  Vincent Sibaud; Nicole R Lebœuf; Henri Roche; Viswanath R Belum; Laurence Gladieff; Marion Deslandres; Marion Montastruc; Audrey Eche; Emmanuelle Vigarios; Florence Dalenc; Mario E Lacouture
Journal:  Eur J Dermatol       Date:  2016-10-01       Impact factor: 3.328

Review 2.  Tweaking microtubules to treat scleroderma.

Authors:  Jacob M van Laar; Tom W J Huizinga
Journal:  PLoS Med       Date:  2005-12-27       Impact factor: 11.069

3.  Scleroderma in a Patient on Capecitabine: Is this a Variant of Hand-Foot Syndrome?

Authors:  Muhammad W Saif; Archana Agarwal; James Hellinger; Dorothy J Park; Elizabeth Volkmann
Journal:  Cureus       Date:  2016-06-30

Review 4.  Paclitaxel-induced diffuse scleroderma with possible scleroderma-renal crisis: a case report and literature review of taxanes-induced scleroderma.

Authors:  Thanika Ketpueak; Wanitcha Chanloung; Kittiya Na Nan; Chontara Pongsananurak; Nuntana Kasitanon; Worawit Louthrenoo
Journal:  Clin Rheumatol       Date:  2022-09-09       Impact factor: 3.650

5.  Unusually thickened skin and neuropathy in a patient with prostate cancer.

Authors:  Albert E Zhou; Karl M Hoegler; Marcia S Driscoll
Journal:  JAAD Case Rep       Date:  2021-06-08
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.